cabalettabio.com - Multiplikator EV/Sales CABA

cabalettabio.com (CABA) - logo korporat

The potential for monopoly pricing power over CAR-T therapy determines the future value of Cabaletta Bio, Inc. (CABA), as illustrated by the precise GURU.Markets chart. The company's price-to-sales ratio confirms that the 0.00 metric serves as the target level. The business relies on the CABA-TrEC ecosystem for treating autoimmune pathologies, utilizing automated bioreactors with mandatory physician involvement in material collection.

Cabaletta Bio, Inc (CABA) - Multiplikator EV/Sales saka 23.11.2025 nganti 19.11.2026

cabalettabio.com - rincian analitis lan metrik utama (CABA)

Pambiji fundamental:Cabaletta Bio (CABA)
Barang unggulan Cabaletta Bio, Inc.

To minimize investment risks, it is necessary to evaluate the asset's capitalization efficiency. This indicator is calculated as the ratio of total enterprise value to revenue, excluding the impact of debt load. By analyzing the trend of company value relative to revenue, an investor determines market expectations for business growth rates. For Cabaletta Bio, Inc. (CABA), this allows for an assessment of the development cost of the CARTA platform. The metric demonstrates how much the market is willing to pay for innovations in targeted cell therapy.

Pesaing langsung

ARGX - Multiplikator EV/Sales|BNTX: Multiplikator EV/Sales|ABVX (Abivax SA) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ADMA Corp|Multiplikator nilai perusahaan marang pendapatan Protagonist Therapeutics PTGX|Nilai perusahaan marang pendapatan IMVT (Immunovant Therapeutics)|Rasio total nilai perusahaan marang pendapatan kiniksa.com|Rasio nilai perusahaan marang pendapatan Grifols Biemat GRFS|Koefisien nilai perusahaan marang pendapatan ADPT (Adaptive Biotechnologies Corporation)|celldex.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Aurinia Pharma AUPH|biocryst.com (BCRX) - Rasio nilai perusahaan marang pendapatan|Vera Therapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Dianthus Therapeutics Inc|Pharvaris NV (PHVS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABCL|Tourmaline Corp - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales PGEN (precigen.com)|Rasio nilai perusahaan marang dodolan pharming.com|NKTR - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Upstream Bio Corp|ZBIO: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Immunome, Inc.|Nilai perusahaan marang pendapatan GOSS|KALV: Nilai bisnis marang pendapatan|Multiplikator EV/Sales SEPN|Nilai perusahaan marang pendapatan Pieris Pharmaceuticals, Inc. PVLA|Multiplikator EV/Sales SVRA (Savara Inc)|Multiplikator EV/Sales Rigel Pharmaceuticals RIGL|AnaptysBio Inc. - Multiplikator EV/Sales|Astria Therapeutics - Koefisien nilai perusahaan marang pendapatan|ENGN: Multiplikator EV/Sales|RAPT - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan JBIO|Aclaris (ACRS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales KYTX|Nilai perusahaan marang pendapatan Tiziana Life Sciences TLSA|Ventyx Biosciences - Nilai perusahaan marang pendapatan|THTX: Rasio nilai perusahaan marang pendapatan|AVTX - Rasio nilai perusahaan marang pendapatan|ELDN: Rasio nilai perusahaan marang pendapatan|Agenus Inc. (AGEN) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Climb Bio Inc|ZURA (Zura Bio Ltd) - Multiplikator EV/Sales|Multiplikator EV/Sales aTyr Pharma Inc|Multiplikator EV/Sales ADAG|Rasio total nilai perusahaan marang pendapatan ImageneBio|Multiplikator EV/Sales STTK (Shattuck Labs Inc)|Multiplikator EV/Sales Equillium, Inc. EQ|CNTB - Rasio nilai perusahaan marang pendapatan|Immunic Therapeutics (IMUX) - Nilai perusahaan marang pendapatan|ATRA: Multiplikator EV/Sales|InflaRx GmbH (IFRX) - Multiplikator EV/Sales|XFOR (x4pharma.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Adicet Bio|Rasio nilai perusahaan marang pendapatan Celularity Inc (CELU)|Nilai perusahaan marang pendapatan INmune Bio Corp INMB|Rasio nilai perusahaan marang pendapatan Barinthus Biotherapeutics plc BRNS|KZR - Nilai perusahaan marang pendapatan|sabbiotherapeutics.com - Multiplikator EV/Sales|akaritx.com (AKTX) - Nilai perusahaan marang pendapatan|ENLV: Multiplikator EV/Sales|QTTB (Q32 Bio Inc) - Rasio nilai perusahaan marang pendapatan|GOVX (geovax.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Edesa Biotech Corp|Multiplikator EV/Sales IBIO|Nilai perusahaan marang pendapatan Carisma Tx CARM|Rasio nilai perusahaan marang pendapatan XTL Biopharmaceuticals Ltd XTLB|Multiplikator EV/Sales Bolt Biotherapeutics BOLT|HCW Biologics - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan aptevotherapeutics.com|AIM (AIM ImmunoTech, Inc.) - Nilai perusahaan marang pendapatan|Aditxt Corp - Nilai bisnis marang pendapatan|GRI (GRI Bio Inc) - Multiplikator EV/Sales|Multiplikator EV/Sales XORTX Therapeutics Inc|Rasio nilai perusahaan marang pendapatan Vyome Therapeutics (HIND)|REVB - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Indaptus Therapeutics, Inc. INDP|Multiplikator EV/Sales scinai.com SCNI|CalciMedica Inc - Multiplikator EV/Sales|AFMD - Multiplikator EV/Sales|ALLK: Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Multiplikator EV/Sales|ITOS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan OCEA (Ocean Biomedical)|TCBP: Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Third Harmonic Bio Inc THRD